ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,700.86
0.46%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Fate Therapeutics Inc (FATE)

  7. Fate Therapeutics Inc (FATE) 뉴스

FATE Fate Therapeutics Inc

3.80
-0.07 (-1.81%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Fate Therapeutics Inc FATE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.07 -1.81% 3.80 13:00:11
개장가 저가 고가 종가 전일 종가
3.88 3.74 3.95 3.80 3.87
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202405:30GLOBEFate Therapeutics Announces Presentation of FT819..
03/04/202421:00GLOBEFate Therapeutics to Present at 23rd Annual Needham Virtual..
03/04/202405:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
19/03/202421:44GLOBEFate Therapeutics Announces Pricing of $100 Million..
06/03/202406:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
05/03/202403:29EDGAR2Form 144 - Report of proposed sale of securities
01/03/202422:00GLOBEFate Therapeutics to Present at Upcoming March Investor..
27/02/202406:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/02/202406:03EDGAR2Form 8-K - Current report
27/02/202406:01GLOBEFate Therapeutics Reports Fourth Quarter and Full Year 2023..
15/02/202422:00GLOBEFate Therapeutics to Webcast Conference Call Reporting..
13/02/202408:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/02/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:01GLOBEFate Therapeutics Reports New Employee Inducement Awards..
31/01/202406:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202403:44EDGAR2Form 144 - Report of proposed sale of securities
26/01/202406:19EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/01/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202406:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202406:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:39EDGAR2Form 144 - Report of proposed sale of securities
10/01/202406:36EDGAR2Form 144 - Report of proposed sale of securities
10/01/202406:36EDGAR2Form 144 - Report of proposed sale of securities
10/01/202406:35EDGAR2Form 144 - Report of proposed sale of securities
08/01/202422:00GLOBEFate Therapeutics Announces Initiation of Phase 1 Clinical..
04/01/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202402:17EDGAR2Form 144 - Report of proposed sale of securities
20/12/202306:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202301:40EDGAR2Form 144 - Report of proposed sale of securities
14/12/202307:00GLOBEFate Therapeutics Reports New Employee Inducement Grants..
28/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202306:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202301:57EDGAR2Form 144 - Report of proposed sale of securities
09/11/202307:10EDGAR2Form 8-K - Current report
09/11/202306:44EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:03EDGAR2Form 8-K - Current report
09/11/202306:01GLOBEFate Therapeutics Reports Third Quarter 2023 Financial..
25/10/202321:00GLOBEFate Therapeutics to Webcast Conference Call Reporting Third..
02/09/202306:29EDGAR2Form 8-K - Current report
31/08/202321:00GLOBEFate Therapeutics to Present at Upcoming September Investor..
22/08/202305:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/08/202304:58EDGAR2Form 144 - Report of proposed sale of securities
09/08/202305:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:07EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
FATE
Fate Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유